Suppr超能文献

环磷酸腺苷-蛋白激酶系统对心肌中钙转运的调控

Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system.

作者信息

Katz A M, Tada M, Kirchberger M A

出版信息

Adv Cyclic Nucleotide Res. 1975;5:453-72.

PMID:165680
Abstract

At least three mechanical changes characterize the response of cardiac muscle to agents that enhance cyclic AMP production. In common with other inotropic interventions, tension is augmented and the rate of tension rise is increased. The third response, acceleration of the rate of relaxation, is characteristic of the actions of beta-adrenergic agonists. These mechanical effects can be attributed to changes in (1) the amount of Ca2+ released during systole, (2) the rate of Ca2+ release at the onset of systole, and (3) the rate at which Ca2+ is reaccumulated by the sarcoplasmic reticulum at the end of systole. The ability of cyclic AMP-dependent protein kinases to phosphorylate the cardiac sarcoplasmic reticulum in vitro parallels stimulation of both Ca2+ transport and Ca2+-activated ATPase. The phosphoprotein formed in the presence of cyclic AMP and protein kinase has the chemical characteristics of a phosphoester, contains mostly phosphoserine, and has an electrophoretic mobility in SDS polyacrylamide gels that corresponds to a protein of 22,000 daltons. This 22,000-dalton protein, tentatively named phospholamban, thus differs from the acyl phosphooprotein formed by the Ca2+-transport ATPase, which as an apparent molecular weight of 90,000 to 100,000 daltons. Phospholamban has not been found in fast skeletal muscle, nor is Ca2+ transport accelerated by cyclic AMP and protein kinase in sarcoplasmic reticulum from these muslces which do not respond to beta-adrenergic agonists with accelerated relaxation. It thus appears likely that phosphorylation of phospholamban correlates both with an increased rate of Ca2+ transport by cardiac sarcoplasmic reticulum in vitro and accelerated relaxation in the intact myocardium. Preliminary findings are consistent with the view that phosphorylation of phospholamban may be related to other actions on Ca2+ fluxes brought about by agents which activate adenylate cyclase in the myocardium, but these interpretations must remain speculative pending more definitive studies.

摘要

至少有三种机械变化可表征心肌对增强环磷酸腺苷(cAMP)生成的药物的反应。与其他变力干预措施相同,张力增强,张力上升速率增加。第三种反应,即舒张速率加快,是β-肾上腺素能激动剂作用的特征。这些机械效应可归因于以下变化:(1)收缩期释放的Ca2+量;(2)收缩期开始时Ca2+的释放速率;(3)收缩期末肌浆网重新积累Ca2+的速率。环磷酸腺苷依赖性蛋白激酶在体外使心肌肌浆网磷酸化的能力与Ca2+转运和Ca2+激活的ATP酶的刺激作用平行。在环磷酸腺苷和蛋白激酶存在下形成的磷蛋白具有磷酸酯的化学特征,主要含有磷酸丝氨酸,并且在SDS聚丙烯酰胺凝胶中的电泳迁移率对应于一种22,000道尔顿的蛋白质。这种22,000道尔顿的蛋白质,暂命名为受磷蛋白,因此不同于由Ca2+转运ATP酶形成的酰基磷蛋白,后者的表观分子量为90,000至100,000道尔顿。在快肌中未发现受磷蛋白,并且在这些对β-肾上腺素能激动剂无舒张加速反应的肌肉的肌浆网中,环磷酸腺苷和蛋白激酶也不会加速Ca2+转运。因此,似乎受磷蛋白的磷酸化既与体外心肌肌浆网Ca2+转运速率的增加相关,也与完整心肌中的舒张加速相关。初步研究结果与以下观点一致,即受磷蛋白的磷酸化可能与心肌中激活腺苷酸环化酶的药物对Ca2+通量的其他作用有关,但在进行更明确的研究之前,这些解释仍属推测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验